1-222563237-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000352967.9(TAF1A):c.1021G>A(p.Gly341Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000223 in 1,612,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
TAF1A
ENST00000352967.9 missense
ENST00000352967.9 missense
Scores
5
9
5
Clinical Significance
Conservation
PhyloP100: 3.60
Genes affected
TAF1A (HGNC:11532): (TATA-box binding protein associated factor, RNA polymerase I subunit A) This gene encodes a subunit of the RNA polymerase I complex, Selectivity Factor I (SLI). The encoded protein is a TATA box-binding protein-associated factor that plays a role in the assembly of the RNA polymerase I preinitiation complex. Alternate splicing results in multiple transcript variants encoding multiple isoforms.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.816
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF1A | NM_005681.4 | c.1021G>A | p.Gly341Arg | missense_variant | 9/11 | ENST00000352967.9 | NP_005672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF1A | ENST00000352967.9 | c.1021G>A | p.Gly341Arg | missense_variant | 9/11 | 1 | NM_005681.4 | ENSP00000327072.6 | ||
TAF1A | ENST00000350027.8 | c.1021G>A | p.Gly341Arg | missense_variant | 9/12 | 2 | ENSP00000339976.4 | |||
TAF1A | ENST00000366890.5 | c.679G>A | p.Gly227Arg | missense_variant | 8/11 | 2 | ENSP00000355856.1 | |||
TAF1A | ENST00000391883.2 | c.*48G>A | downstream_gene_variant | 5 | ENSP00000375755.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152036Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152036
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250252Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135322
GnomAD3 exomes
AF:
AC:
7
AN:
250252
Hom.:
AF XY:
AC XY:
3
AN XY:
135322
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1460674Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 726700
GnomAD4 exome
AF:
AC:
30
AN:
1460674
Hom.:
Cov.:
31
AF XY:
AC XY:
14
AN XY:
726700
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152036Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74282
GnomAD4 genome
AF:
AC:
6
AN:
152036
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 06, 2022 | - - |
Cardiomyopathy, familial restrictive, 6 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Columbia University Laboratory of Personalized Genomic Medicine, Columbia University Medical Center | Jul 30, 2021 | The paternally inherited c.1021G>A, p.Gly341Arg variant in the TAF1A gene in this affected child is a missense variant, which results in a substitution of Glycine residue to Arginine at position 341/451 of the protein, predicted to be damaging by multiple in silico prediction tools (SIFT and PROVEAN). This variant is rare from the gnomAD database with allele frequency 0.00002797 (7/250252 heterozygotes, 0 homozygote) indicating that it is not a common benign occurrence in the populations represented in the database. This variant has been previously reported in two cardiomyopathy sisters (2-3 years old) in compound heterozygous state with another missense variant in the TAF1A gene (PMID: 28472305). TAF1A encodes a TATA box-binding protein-associated factor which is required for RNA polymerase I to synthesize ribosomal RNA. In one study, the TAF1A gene specific subcellular phenotype was identified in approximately 50% of the cardiomyocytes of the affected sisters and was absent in pediatric normal and DCM controls. In a functional study of this gene, TAF1A-/- zebrafish recapitulate a heart failure phenotype (PMID: 28472305). However, since only one pediatric cardiomyopathy family has been reported with compound heterozygous TAF1A variants, the gene-disease association for TAF1A with pediatric cardiomyopathy remains uncertain. Given these evidences, TAF1A is a gene of unknown significance and therefore the c.1021G>A, p.Gly341Arg variant is classified as variant of unknown significance. - |
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;T;.
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;D
Vest4
MutPred
0.47
.;Gain of MoRF binding (P = 0.012);Gain of MoRF binding (P = 0.012);
MVP
MPC
0.99
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at